Literature DB >> 15050530

Palmitate increases nitric oxide synthase activity that is involved in palmitate-induced cell death in cardiomyocytes.

Michael Y C Tsang1, Scott E Cowie, Simon W Rabkin.   

Abstract

The objective of this study was to test the hypothesis that nitric oxide synthase (NOS) is subjected to regulatory control by palmitate, and that nitric oxide (NO) is operative in palmitate-induced cell death. Palmitate induced a significant ( p<0.05 ) concentration-dependent increase in NOS activity measured by the conversion of [(3)H]arginine to [3H]citrulline in embryonic chick cardiomyocytes. Cellular eNOS and iNOS, determined by immunocytochemistry, were increased by palmitate. Western blotting also showed that palmitate, 500 microM for 4h, significantly increased the amount of cellular of eNOS and iNOS by 36.2+/-6.5% ( p<0.001 ) and 38.4+/-14.4% ( p<0.05 ), respectively. The NOS inhibitor L-NAME significantly ( p<0.05 ) accentuated palmitate-induced cell death These data suggest that palmitate has a bifunctional effect on cell viability--in addition to loss of cell viability, palmitate stimulates NOS activity by inducing an increase in cellular eNOS and iNOS with the resultant NO production serving to protect cardiomyocytes from palmitate-induced cell death.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15050530     DOI: 10.1016/j.niox.2004.01.005

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  8 in total

1.  Palmitate-Induced Translocation of Caveolin-3 and Endothelial Nitric Oxide Synthase in Cardiomyocytes.

Authors:  Catherine J Knowles; Megan Dionne; Martina Cebova; Ilka M Pinz
Journal:  Online J Biol Sci       Date:  2011

2.  The metalloporphyrin FeTPPS but not by cyclosporin A antagonizes the interaction of peroxynitrate and hydrogen peroxide on cardiomyocyte cell death.

Authors:  Shaun S Klassen; Simon W Rabkin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-09-05       Impact factor: 3.000

3.  Group VIA phospholipase A2 mitigates palmitate-induced β-cell mitochondrial injury and apoptosis.

Authors:  Haowei Song; Mary Wohltmann; Min Tan; Jack H Ladenson; John Turk
Journal:  J Biol Chem       Date:  2014-03-19       Impact factor: 5.157

4.  Mitochondrial dysfunction and activation of iNOS are responsible for the palmitate-induced decrease in adiponectin synthesis in 3T3L1 adipocytes.

Authors:  Min Jae Jeon; Jaechan Leem; Myoung Seok Ko; Jung Eun Jang; Hye-Sun Park; Hyun Sik Kim; Mina Kim; Eun Hee Kim; Hyun Ju Yoo; Chul-Ho Lee; In-Sun Park; Ki-Up Lee; Eun Hee Koh
Journal:  Exp Mol Med       Date:  2012-09-30       Impact factor: 8.718

5.  Synergy analysis reveals association between insulin signaling and desmoplakin expression in palmitate treated HepG2 cells.

Authors:  Xuewei Wang; Aritro Nath; Xuerui Yang; Amanda Portis; S Patrick Walton; Christina Chan
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

6.  Novel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in mice.

Authors:  Xavier Xifró; Laura Vidal-Sancho; Pere Boadas-Vaello; Carlos Turrado; Jordi Alberch; Teresa Puig; Enrique Verdú
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

7.  Palmitate diet-induced loss of cardiac caveolin-3: a novel mechanism for lipid-induced contractile dysfunction.

Authors:  Catherine J Knowles; Martina Cebova; Ilka M Pinz
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

8.  A novel mechanism by which SDF-1β protects cardiac cells from palmitate-induced endoplasmic reticulum stress and apoptosis via CXCR7 and AMPK/p38 MAPK-mediated interleukin-6 generation.

Authors:  Yuguang Zhao; Yi Tan; Shugang Xi; Yunqian Li; Cai Li; Jiuwei Cui; Xiaoqing Yan; Xiaokun Li; Guanjun Wang; Wei Li; Lu Cai
Journal:  Diabetes       Date:  2013-02-19       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.